ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2856

Influence Of Mechanical Symptoms On Treatment Outcomes For Meniscal Tear In The Setting Of Osteoarthritis

Jeffrey N. Katz1, John Wright2, Lisa A. Mandl3, Brian Cole4, Laurel Donnell-Fink5, Ali Guermazi6, Morgan Jones7, Bruce Levy8, Scott Martin5, Robert Marx9, Anthony Miniaci10, Kurt P. Spindler11, Rick Wright12 and Elena Losina13, 1Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, 2Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Rush University, Chicago, IL, 5Brigham and Women's Hospital, Boston, MA, 6Boston University, Boston, MA, 7Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, 8Orthopedics, Mayo Clinic, Rochester, MN, 9Orthopedic Surgery, Hospital for Special Surgery, New York, NY, 10Orthopedics, Cleveland Clinic, Cleveland, OH, 11Vanderbilt University, Nashville, TN, 12Orthopedics, Washington University, Saint Louis, MO, 13Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: meniscectomy, osteoarthritis and prognostic factors

  • Tweet
  • Email
  • Print
Session Information

Title: Orthopedics, Low Back Pain, Rehabilitation and Mechanisms of Pain in Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Clinicians are challenged to identify those patients with knee pain, osteoarthritis (OA) and imaging evidence of a meniscal tear (MT) who are likely to benefit from arthroscopic partial meniscectomy (APM). Traditionally, clinicians have recommended that patients with “mechanical symptoms” (e.g. locking, clicking, catching) consider APM. The MeTeOR (MT in OA Research) Trial demonstrated similar symptomatic relief in persons treated with APM and those treated initially with physical therapy (PT), with referral for APM if PT did not relieve pain. We analyzed MeTeOR data to compare improvement in mechanical symptoms between subjects that received APM and those that received PT; and to examine whether frequency of baseline mechanical symptoms influenced pain relief at 6 month follow-up.

Methods: MeTeOR is a seven-center RCT of APM vs. standardized PT in subjects age 45+ with symptomatic MT and OA. The baseline survey asked about 5 mechanical symptoms (clicking, catching, popping, locking, giving way), each with 5 responses (“never” to “several times a day”). We summed these 5 items to create a mechanical symptom score. We used t-tests to compare patients who had surgery (at the outset or after crossing over) vs. those treated with PT with respect to changes in mechanical symptom score from baseline to 6 months. We compared baseline mechanical symptom scores with changes over 6 months in WOMAC Pain using correlations (presented as crude r-squared).  We used multivariable linear regression with an interaction to assess whether the association between baseline mechanical symptom score and improvement in WOMAC Pain over 6 months differed between subjects treated with APM vs. those treated with PT.

Results:   351 subjects participated, 57% female, mean age 58.The baseline mean mechanical symptom score was 10.4 (SD 4.9) and mean WOMAC Pain 41.0 (SD 17.8, possible range 0-100 with 0=best). Subjects improved in WOMAC Pain over 6 months by a mean of 21.4 points (SD 18.7). Improvement over 6 months in mechanical symptom score was greater among subjects treated with APM (0.82 SD’s) than among those treated with PT (0.42 SD’s; p=0.01). However, improvement in mechanical symptom score explained just 8% of variability in improvement in WOMAC Pain. We did not find an association between baseline mechanical symptom score and improvement in WOMAC Pain (r-squared <0.02 for both APM- and PT-treated subjects.) Associations between individual symptom frequencies (e.g. locking, catching) and change in WOMAC pain and function scores were also negligible. The association of baseline mechanical symptom score and change in pain score did not differ between subjects receiving APM and those receiving PT (p for interaction=0.44).

Conclusion: While mechanical symptom scores improved more following APM than following PT, MeTeOR data did not support the clinical teaching that frequent mechanical symptoms at baseline predict greater pain relief following APM than following PT.  Thus, clinicians should not rely upon the frequency of mechanical symptoms to predict pain relief following APM but can advise their patients that mechanical symptoms are more likely to resolve with surgery than without.


Disclosure:

J. N. Katz,

OARSI,

6,

JBJS,

9;

J. Wright,
None;

L. A. Mandl,

Boehringer Ingelheim,

2;

B. Cole,

Abthroscopy Association of North America,

6,

Arthrex ,

5,

Carticept,

5,

DJ Orthopedics ,

5,

Genzyme,

5,

Johnson and Johnson/ DePuy,

5,

Regentis,

5,

Zimmer,

5,

Multiple,

9,

Major League Baseball,

2,

Musculoskeletal Transplant Foundation,

2,

Orthopedic Research and Education Foundation,

2,

NIH/MIMAS,

2,

Arthrex,

2,

Zimmer,

2,

Arthrosurface,

2,

Johnson & Johnson,

2,

Medipost,

2,

Genzyme Corporation,

8,

Arthrex ,

7,

DJ Orthopedics ,

7,

Elsevier ,

7,

WB Saunders ,

7,

Carticept and Regentis ,

1,

Am J Orthopedics, Am Journal of Sports Medicine, Cartilage, J Shoulder and Elbow Surgery ,

9,

Da Orthopedics, Ossur, Smith and Nephew ,

9;

L. Donnell-Fink,
None;

A. Guermazi,

Boston Imaging Core Lab,

1,

Merck Serono,

5,

Sanofi-Aventis Pharmaceutical,

5,

TissueGene,

5;

M. Jones,

Allergan Inc.,

5;

B. Levy,

Corrona,

6,

Arthrex,

5,

Arthrex, VOT solutions,

7;

S. Martin,
None;

R. Marx,

Journal of Bone and Joint Surgery,

6,

Demos Medical Publishing,

7;

A. Miniaci,

Arthrosurface, Stryker,

5,

DJ Orthopedics, Stryker, Arthrex,

2,

Arthrosurface,

8;

K. P. Spindler,

Smith & Nephew, Inc.,

9;

R. Wright,

Flexion Therapeutics,

5,

Isto Technologies,

5,

Smith Nephew,

2,

Wolters Kluwer Lippincott Williams and Wilkins,

7;

E. Losina,

JBJS,

9.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-mechanical-symptoms-on-treatment-outcomes-for-meniscal-tear-in-the-setting-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology